Clinical

In the midst of the war on obesity, a clear winner has emerged in the battle between two weight-loss injections. Zepbound (tirzepatide), made by Fortune 500 company Eli Lilly & Co., outperformed competitor Wegovy (semaglutide), a Novo…

The first scientific presentation of previously announced data from Cohort 1 of an ongoing Phase 1b clinical trial evaluating low-dose LTI-03 (2.5 mg twice daily) in IPF, confirms positive trends in seven of the eight biomarkers evaluated,…

Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical…

This section is Partnership Content ProvidedThe content in this section has been provided by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Globe…

Article contentVIENNA — AOP Orphan Pharmaceuticals GmbH (AOP Health) continues a successful clinical research program in hematology/oncology by accepting two abstracts for presentation at the 2024 European Hematology Association (EHA)…

This section is Partnership content providedThe content in this section is provided by Business Wire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Business wire…

new Taipei city, May 11, 2024 /PRNewswire/ -- Calliway Biopharmaceuticals (Calliway) is pleased to announce its partnership to share the latest clinical developments in the upcoming 2024 year Vital International Convention on Wednesday,…

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire…

Bristol Myers Squibb (BMS) has the broadest ongoing cell therapy development program in CD19-positive malignancies with Breyanzi, which also includes trials investigating its use in patients with relapsed/refractory mantle cell lymphoma…

Health food company Foodhak has announced that it has successfully designed nutritious meals using generative AI to process the results of more than 200,000 clinical health trials. In the world's first, the company is now at the…